The Food and Drug Administration is making a regulatory change that will give retail pharmacies the ability to sell abortion pills with a prescription from a licensed healthcare provider. The medication, mifepristone, has previously been dispensed through medical care facilities and mail-order pharmacies.
View Original Article
RetailWire is retailing’s premier online discussion forum, serving the industry as a free resource for over 18 years with compelling content that goes well beyond conventional headline reporting. Each business morning, our editors post timely topics worthy of commentary by the RetailWire BrainTrust panel of industry experts and general readership. The results are virtual round tables of industry opinion and advice covering the most dynamic trends and issues affecting the retailing industry.
https://retailwire.com/
Do you like RetailWire's articles? Follow on social!